May 08, 2026 | Trump Plans to Fire FDA Commissioner Makary; Leqembi SC Delayed to August

FDA leadership in crisis — multiple outlets report Trump will fire Commissioner Makary after 14 turbulent months. Leqembi SC review extended three months to August 24. Bayer acquires Perfuse for $2.45B; Daiichi Sankyo takes $610M ADC manufacturing hit; Gilead targets $1B in Yeztugo sales.Visit us at www.thepharmcloseout.compharma, pharmaceutical, FDA, clinical trials, biotech, drug approvals, healthcare, pharma podcast, The Pharma Closeout, Marty Makary, Trump, Leqembi, lecanemab, Eisai, Biogen, Bayer, Perfuse Therapeutics, glaucoma, Daiichi Sankyo, ADC, Enhertu, Gilead, Yeztugo, lenacapavir, PrEP, HIV, Bizengri, zenocutuzumab, CNPV, Partner Therapeutics, Artiva, rheumatoid arthritis, Odyssey Therapeutics, IPO, Entrada, Capricor, Duchenne, DMD, Angelini, Catalyst, Argenx, Vyvgart, Novo Nordisk, Wegovy, Sarepta, Lilly, Sanofi